Wilmer Cutler Pickering Hale and Dorr, Axinn, Veltrop & Harkrider and Tidal Partners advised Dedrone on the transaction, and Sullivan & Cromwell and Morgan, Lewis &...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Karyopharm Therapeutics Inc. on the transactions. Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Akamai Technologies, Inc. in the transaction. Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, announced that...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Alethea in the transaction. Alethea, a leading technology company in disinformation detection and mitigation, announced it has raised $20 million in Series...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Duro in the transaction. Duro, a leading Cloud-native PLM platform in hardware engineering, announced it has raised $7.5 million...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Analog Devices, Inc. in the offering, and Cravath Swaine & Moore represented the underwriters. Analog Devices, Inc. (NASDAQ: ADI) announced its...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented State Street Corporation, and Cravath Swaine & Moore represented the underwriters. State Street Corporation (“State Street”) (NYSE: STT) announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray and Wilmer Cutler Pickering Hale and Dorr represented Xilio Therapeutics, Inc. in the deal. Xilio Therapeutics, Inc.(Nasdaq: XLO), announced it has entered into...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt acted as Canadian counsel to Milestone Pharmaceuticals Inc. in the offering, Cooleyacted as US counsel to the company. Wilmer Cutler Pickering Hale...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Linden Capital Partners, Wilmer Cutler Pickering Hale and Dorr represented Alcresta Therapeutics and Wilson Sonsini Goodrich & Rosati advised HealthQuest Capital. Linden...
You must be a Standard 1 Year member to access this content.
Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the...
You must be a Standard 1 Year member to access this content.
